Nina Ellen Tolkoff-Rubin, M.D.
Co-Author
This page shows the publications co-authored by Nina Tolkoff-Rubin and Robert Colvin.
Connection Strength
1.656
-
Hydroxyurea for Treatment of Nephrotic Syndrome Associated With Polycythemia Vera. Am J Kidney Dis. 2016 Sep; 68(3):465-8.
Score: 0.165
-
Immune Complex Tubulointerstitial Nephritis Due to Autoantibodies to the Proximal Tubule Brush Border. J Am Soc Nephrol. 2016 Feb; 27(2):380-4.
Score: 0.158
-
Clinical role of the renal transplant biopsy. Nat Rev Nephrol. 2012 Jan 10; 8(2):110-21.
Score: 0.123
-
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int. 2011 Oct; 80(8):879-85.
Score: 0.118
-
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant. 2011 Jul; 11(7):1464-77.
Score: 0.118
-
Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts. Transplant Proc. 2006 Dec; 38(10):3427-9.
Score: 0.086
-
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int. 2002 Jun; 61(6):2201-9.
Score: 0.063
-
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol. 2002 Mar; 13(3):779-787.
Score: 0.062
-
Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol. 2001 Mar; 12(3):574-582.
Score: 0.058
-
Resolution of a High Grade and Metastatic BK Polyomavirus-Associated Urothelial Cell Carcinoma Following Radical Allograft Nephroureterectomy and Immune Checkpoint Treatment: A Case Report. Transplant Proc. 2020 Nov; 52(9):2720-2725.
Score: 0.055
-
Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol. 1999 Oct; 10(10):2208-14.
Score: 0.052
-
Viruses and thrombotic microangiopathy. Transplantation. 1999 Sep 15; 68(5):710-1.
Score: 0.052
-
Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol. 1999 Jan; 10(1):146-53.
Score: 0.050
-
IGA nephropathy in HLA-identical siblings. Transplantation. 1978 Dec; 26(6):430-3.
Score: 0.049
-
De novo collapsing glomerulopathy in renal allografts. Transplantation. 1998 May 15; 65(9):1192-7.
Score: 0.048
-
Recurrent collapsing glomerulopathy. Transplantation. 1998 Apr 15; 65(7):1009-10.
Score: 0.047
-
Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease. Lancet. 1996 Jan 27; 347(8996):231-3.
Score: 0.041
-
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant. 2014 Jul; 14(7):1599-611.
Score: 0.036
-
Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine. Am J Transplant. 2010 Nov; 10(11):2463-71.
Score: 0.028
-
B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant. 2009 Sep; 9(9):2126-35.
Score: 0.026
-
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008 Jan 24; 358(4):353-61.
Score: 0.023
-
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant. 2006 Sep; 6(9):2121-33.
Score: 0.021
-
My most interesting cases. Clin Transpl. 2006; 580-2.
Score: 0.020
-
Effects of long-term lithium administration on renal structure and function in rats. A distinctive tubular lesion. Lab Invest. 1984 May; 50(5):526-35.
Score: 0.018
-
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant. 2003 Jan; 3(1):74-8.
Score: 0.016
-
Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation. 2001 Jul 15; 72(1):77-83.
Score: 0.015
-
Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation. 2001 Mar 15; 71(5):652-8.
Score: 0.014
-
The kidney transplant program at the Massachusetts general hospital. Clin Transpl. 2001; 123-30.
Score: 0.014
-
Renal disease associated with hepatitis C infection after kidney and liver transplantation. Transplantation. 2000 Jul 27; 70(2):255-61.
Score: 0.014
-
The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study. Transplantation. 1999 Mar 15; 67(5):737-41.
Score: 0.013
-
Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation. 1998 Dec 15; 66(11):1460-4.
Score: 0.012
-
Nephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis. Transplantation. 1997 Oct 15; 64(7):1073-6.
Score: 0.011
-
Real-time monitoring of renal function during ischemic injury in the rhesus monkey. Ren Fail. 1995 Sep; 17(5):489-502.
Score: 0.010
-
A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation. 1993 Apr; 55(4):766-72; discussion 772-3.
Score: 0.008
-
Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med. 1983 Feb 10; 308(6):307-13.
Score: 0.004
-
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation. 1981 Dec; 32(6):535-9.
Score: 0.004
-
Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med. 1981 Jul 09; 305(2):57-63.
Score: 0.004
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.